Unknown

Dataset Information

0

Noribogaine reduces nicotine self-administration in rats.


ABSTRACT: Noribogaine, a polypharmacological drug with activities at opioid receptors, ionotropic nicotinic receptors, and serotonin reuptake transporters, has been investigated for treatment of substance abuse-related disorders. Smoking cessation has major benefits for both individuals and society, therefore the aim of this study was to evaluate the potential of noribogaine for use as a treatment for nicotine dependence. Adult male Sprague-Dawley rats were trained to self-administer nicotine intravenous. After initial food pellet training, followed by 26 sessions of nicotine self-administration training, the rats were administered noribogaine (12.5, 25 or 50 mg/kg orally), noribogaine vehicle, varenicline or saline using a within-subject design with a Latin square test schedule. Noribogaine dose-dependently decreased nicotine self-administration by up to 64% of saline-treated rats' levels and was equi-effective to 1.7 mg/kg intraperitoneal varenicline. Noribogaine was less efficient at reducing food pellets self-administration than at nicotine self-administration, inhibiting the nondrug reinforcing effects of palatable pellets by 23% at the highest dose. These results suggest that noribogaine dose-dependently attenuates drug-taking behavior for nicotine, attenuates the reinforcing effects of nicotine and is comparable to varenicline power in that regard. The findings from the present study hold promise for a new therapy to aid smoking cessation.

SUBMITTER: Chang Q 

PROVIDER: S-EPMC4456428 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Noribogaine reduces nicotine self-administration in rats.

Chang Qing Q   Hanania Taleen T   Mash Deborah C DC   Maillet Emeline L EL  

Journal of psychopharmacology (Oxford, England) 20150520 6


Noribogaine, a polypharmacological drug with activities at opioid receptors, ionotropic nicotinic receptors, and serotonin reuptake transporters, has been investigated for treatment of substance abuse-related disorders. Smoking cessation has major benefits for both individuals and society, therefore the aim of this study was to evaluate the potential of noribogaine for use as a treatment for nicotine dependence. Adult male Sprague-Dawley rats were trained to self-administer nicotine intravenous.  ...[more]

Similar Datasets

| S-EPMC7660018 | biostudies-literature
| S-EPMC4267270 | biostudies-literature
| S-EPMC7297109 | biostudies-literature
| S-EPMC3975132 | biostudies-literature
| S-EPMC7796964 | biostudies-literature
| S-EPMC2040467 | biostudies-literature
| S-EPMC4179974 | biostudies-literature
| S-EPMC6305389 | biostudies-literature
| S-EPMC6697865 | biostudies-literature
| S-EPMC4399837 | biostudies-literature